Altogen Biosystems公司成立于1978年，是体外诊断工业和全球实验室原材料的主要供应商。我们为我们行业中最大的跨国公司提供广泛的人类纯化蛋白；单克隆和多克隆抗体；真菌、寄生、细菌和病毒抗原；以及用于体外诊断的疾病状态血浆。

Altogen Biosystems is a biotechnology company that develops and manufactures transfection kits for life sciences research, drug discovery and development. Altogen® In Vivo transfection reagents provide effective delivery of biomolecules into target tissues. Cell transfection kits are optimized for specific cancer cell lines and primary cell cultures.  Efficient delivery of cargo molecules (DNA, RNA, proteins) enabled by advanced reagent formulation and optimized transfection protocols. Altogen Biosystems develops new in vitro and in vivo delivery technologies by applying polymer chemistry, molecular and cell biology expertise.

Altogen Biosystems公司的主要产品包括：

Fungal, protozoan, bacterial and viral antigens

Monoclonal antibodies

Polyclonal antibodies

Disease state human plasma

Purified native and recombinant human proteins

艾美捷科技代理Innovative Biochips品牌全系列产品

Innovative Biochips是休斯顿德克萨斯医学中心（TMC）的衍生公司，专注于开发先进的微流控技术，以尖端的灵敏度和高通量解决传统生物技术面临的难题。科研团队和工程师在为各类生物和生物医学应用开发新型微流体技术方面积累了的经验。通过不断创新和优化技术，Innovative Biochips为生命科学研究提供了更精准的工具，推动生物医学领域的进步。主要产品包括单细胞克隆分析、单细胞成像和配对、球状细胞培养等。

▍Innovative Biochips公司产品线

● 单细胞PCR与测序技术：本系列产品融合标准设备制式与创新微流控设计，提供多种简易、快速、经济的单细胞分离方案：实现单细胞向超微量液体环境的高效转移；完美适配单细胞裂解、PCR及测序等遗传分析流程。

● 单细胞克隆：在重组蛋白生产、基因功能研究与药物筛选中应用广泛。1CellPlate®-96孔超微量微流控板采用标准96孔板规格，结合独特的"孔中孔"微流控设计，为癌细胞、杂交瘤细胞、CHO细胞、CRISPR编辑细胞及干细胞等稳定细胞株开发，提供前所未有的简易单细胞分离方案。

● 单细胞检测：1CellPlate®-Assay 超低体积 96 孔微流控微孔板结合了超小孔和微流控网络，满足了单细胞细胞因子检测的需求。单细胞分泌的细胞因子可被收集并通过质谱进行深度分析。此外，具有显著高细胞因子分泌量的单细胞，也能通过常规移液器轻松回收，用于包括克隆或 PCR 测序在内的下游分析。

● 自动化寿命检测：自动解剖芯片 (AD-Chip) 结合延时显微技术，可在 3 天内对 20 种不同菌株的逾万个单酵母细胞进行自动化全寿命追踪。该芯片能够在整个衰老过程中对单细胞进行高分辨率荧光成像。

▍Innovative Biochips产品列表

Dendritics公司主要关注人类树突状细胞，希望找到能够促使CD34+造血前体细胞转化为树突状细胞（在GM-CSF和TNF-alpha存在的情况下）的细胞因子。在1992-2005年间，大量的研究使得研究者对人类树突状细胞的产生、细胞通路、C-type凝集素受体的功能及Toll-like受体的活性有了更深的理解。

DENDRITICS was started in 2005 by former members of SCHERING PLOUGH Laboratory for Immunological Research (LIR) in Dardilly, France. From their long experience at LIR, the team members of DENDRITICS have gathered complementary scientific and technological knowledge in different areas of immunology. The initial focus of LIR was in the biology of B lymphocytes, elaboration of human monoclonal antibodies, and in cytokine discovery (IL-3, IL-4, IL-7, IL-10, IL-17, GM-CSF) together with our colleagues of DNAX Research Institute in Palo Alto, California.

Our interest in cytokines led to the finding that human dendritic cells (DCs) could be generated in vitro from CD34+ hematopoietic progenitors cultured in the presence of GM-CSF and TNF-alpha.

The period from 1992 to 2005 saw the specialization of LIR in DC biology and was fuelled by a large-scale effort to discover and study the function of genes specifically expressed by these cells. This program led to a number of findings that contributed in particular to understanding the heterogeneity of DCs, the pathways regulating DC migration, the function of C-type lectin receptors in DCs and the activity of Toll-like receptors in DCs. Many novel genes were discovered through screening of cDNA libraries or through monoclonal antibodies raised against DCs.

更多详情请联系 

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com